Antibiotic resistance profiles of the three main carbapenemase gene-harboring <i>A</i>. <i>baumannii</i> clones (MIC μg/ml).

IPM, imipenem; MEM, meropenem; CSL, cefoperazone-sulbactam; SAM, ampicillin-sulbactam; FEP, cefepime; TZP, piperacillin-tazobactam; CAZ, ceftazidime; CRO, ceftriaxone; AMK, amikacin; CIP, ciprofloxacin; LEV, levofloxacin; SXT, trimethoprim-sulfamethoxazole; POL, polymixin B; MNO, minocycline; TGC, tigecycline R, resistant; S, susceptible a CLSI (2007) breakpoint for cefoperazone was used for cefoperazone-sulbactam in this study. b U.S. FDA criteria for tigecycline were used in this study (susceptibility is defined as ≤ 2μg/ml; resistance as ≥ 8 μg/ml). Antibiotic resistance profiles of the three main carbapenemase gene-harboring A. baumannii clones (MIC μg/ml).